ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.979
0.04%
Brent Oil
83.195
0.52%
Bitcoin
63,975.35
0.13%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. PAVmed Inc (PAVM)

  7. PAVmed Inc (PAVM) Noticias

PAVM PAVmed Inc

2.07
-0.17 (-7.59%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
PAVmed Inc PAVM NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.17 -7.59% 2.07 17:09:14
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
2.20 2.0401 2.20 2.07 2.24
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
03/5/202407:35PRNUSPAVmed to Hold a Business Update Conference Call and Webcast..
02/5/202407:35PRNUSLucid Diagnostics to Hold a Business Update Conference Call..
02/5/202406:49PRNUSLucid Diagnostics Announces Peer-Reviewed Publication of..
30/4/202406:35PRNUSPAVmed Subsidiary, Veris Health, Signs Memorandum of..
29/4/202407:47PRNUSLucid Diagnostics Partners with the Esophageal Cancer Action..
08/4/202407:30PRNUSLucid Diagnostics to Participate in Fireside Chat at the..
26/3/202418:32PRNUSPAVmed Provides Business Update and Fourth Quarter and Full..
21/3/202408:30PRNUSLucid Diagnostics Announces Positive Data from the First..
21/3/202407:30PRNUSPAVmed Launches Incubator to Advance Existing Pipeline..
20/3/202407:30PRNUSLucid Diagnostics Announces Multiple Presentations at the..
13/3/202407:30PRNUSPAVmed to Hold a Business Update Conference Call and Webcast..
12/3/202407:30PRNUSLucid Diagnostics to Hold a Business Update Conference Call..
08/3/202415:30EDGAR2Form 8-K - Current report
23/2/202415:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202415:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202415:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202415:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202415:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202415:45EDGAR2Form SC 13D/A - General statement of acquisition of..
16/2/202416:00PRNUSLucid Diagnostics Provides Update Regarding World Trade..
15/2/202406:45PRNUSLucid Diagnostics Chairman & CEO, Dr. Lishan Aklog,..
14/2/202414:38EDGAR2Form SC 13G - Statement of acquisition of beneficial..
09/2/202415:30EDGAR2Form 8-K - Current report
08/2/202406:45PRNUSLucid Diagnostics Executes Contract to Provide EsoGuard®..
06/2/202416:17EDGAR2Form S-8 - Securities to be offered to employees in employee..
06/2/202416:16EDGAR2Form S-8 - Securities to be offered to employees in employee..
02/2/202416:11EDGAR2Form SC 13D/A - General statement of acquisition of..
30/1/202416:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202416:05EDGAR2Form 8-K - Current report
08/1/202415:30EDGAR2Form 8-K - Current report
12/12/202307:30PRNUSLucid Diagnostics Announces Peer-Reviewed Publication of..
11/12/202308:00PRNUSPAVmed Provides Additional Details for Upcoming Stock..
05/12/202307:46EDGAR2Form 8-K - Current report
04/12/202315:20PRNUSPAVmed Announces Dividend of Lucid Diagnostics Common Stock..
16/11/202308:00PRNUSLucid Diagnostics Strengthens and Expands Market Access and..
14/11/202316:43PRNUSPAVmed Provides Business Update and Third Quarter Financial..
13/11/202316:40PRNUSLucid Diagnostics Provides Business Update and Third Quarter..
13/11/202316:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202308:00PRNUSLucid Diagnostics Launches Next-Generation EsoGuard®..
02/11/202308:18PRNUSLucid Diagnostics to Present at Canaccord Genuity Medtech,..
01/11/202308:10PRNUSPAVmed to Hold a Business Update Conference Call and Webcast..
31/10/202308:00PRNUSLucid Diagnostics Announces PREVENT and PREVENT-FF..
31/10/202307:55PRNUSLucid Diagnostics to Hold a Business Update Conference Call..
18/10/202308:18EDGAR2Form 8-K - Current report
21/9/202307:30PRNUSPAVmed and Lucid Diagnostics to Participate in Panel..
07/9/202308:26PRNUSLucid Diagnostics Releases Positive Data from First..
06/9/202308:00PRNUSLucid Diagnostics Releases Positive Data Demonstrating..
24/8/202308:00PRNUSLucid Diagnostics Executes First Direct Employer Contract to..
15/8/202319:17PRNUSPAVmed Provides Business Update and Second Quarter Financial..
14/8/202317:48PRNUSLucid Diagnostics Provides Business Update and Second..

Su Consulta Reciente

NASDAQ
PAVM
PAVmed
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados